On July 15, 2025, ABVC BioPharma, Inc. finalized an agreement to acquire land in Taiwan from director Shuling Jiang for 2,035,136 shares valued at approximately $3,857,975 and included a warrant for purchasing an additional 1,000,000 shares at $2.50 each. This transaction is a related party deal and may increase Jiang's ownership in the company to about 23.3%.